Cargando…
Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) continues to be a leading challenge in modern oncology. Early detection via blood-based screening tests has the potential to cause a stage-shift at diagnosis and improve clinical outcomes. Tumor associated autoantibodies (TA-AAbs) have previously shown the...
Autores principales: | Welberry, Christopher, Macdonald, Isabel, McElveen, Jane, Parsy-Kowalska, Celine, Allen, Jared, Healey, Graham, Irving, William, Murray, Andrea, Chapman, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202612/ https://www.ncbi.nlm.nih.gov/pubmed/32374744 http://dx.doi.org/10.1371/journal.pone.0232247 |
Ejemplares similares
-
Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma
por: Middleton, Catrin H., et al.
Publicado: (2014) -
Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT(®)-Lung Test
por: Macdonald, Isabel K., et al.
Publicado: (2012) -
Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection
por: Macdonald, Isabel K., et al.
Publicado: (2012) -
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
por: Chapman, Caroline J., et al.
Publicado: (2012) -
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
por: Wang, Xiaoping, et al.
Publicado: (2018)